Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Undergraduate School

Saint Joseph's College

1975, Philadelphia, PA

Medical School

University of Pennsylvania School of Medicine

1979, Philadelphia, PA

Internship

Children's Hospital of Philadelphia

1980, Philadelphia, PA

Residency

Children's Hospital of Philadelphia

1982, Philadelphia, PA

Fellowship

Cardiac Electrophysiology

Boston Children's Hospital

1984, Boston, MA

Fellowship

Cardiac Electrophysiology

Massachusetts General Hospital

1985, Boston, MA

Certifications

  • American Board of Pediatrics (Cardiology)
  • American Board of Pediatrics (General)

Professional History

I joined the staff at Boston Children’s Hospital in 1985 to establish a pediatric arrhythmia service, which has now grown to be one of the largest programs of its kind for clinical care, research, and training. I am principally involved in catheter ablation of arrhythmias, management of postoperative arrhythmias, and care of the adult with congenital heart disease.

Media

Caregiver Profile

Meet Dr. Edward Walsh

Publications

  1. The current state of Pediatric and Congenital Electrophysiology Society care delivery for adults with congenital heart disease. Heart Rhythm. 2025 May 08. View Abstract

  2. The American Association for Thoracic Surgery (AATS) 2025 Expert Consensus Document: Management of Ebstein anomaly in children and adults. J Thorac Cardiovasc Surg. 2025 Apr 29. View Abstract

  3. Expert-Level Automated Diagnosis of the Pediatric ECG Using a Deep Neural Network. JACC Clin Electrophysiol. 2025 Mar 01. View Abstract

  4. A Natural History Study of Timothy Syndrome. Orphanet J Rare Dis. 2024 Nov 23; 19(1):433. View Abstract

  5. Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease. J Am Coll Cardiol. 2024 Nov 19; 84(21):2102-2112. View Abstract

  6. Ventricular septation for double inlet ventricle: Avoiding conduction injury. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1055-1065. View Abstract

  7. Efficacy and safety of early postoperative ablation in patients with congenital heart disease. Heart Rhythm. 2025 May; 22(5):1330-1336. View Abstract

  8. Surgical debulking of large ventricular fibromas in children. J Thorac Cardiovasc Surg. 2025 Jan; 169(1):186-194. View Abstract

  9. A Natural History Study of Timothy Syndrome. medRxiv. 2024 May 21. View Abstract

  10. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease. J Cardiovasc Electrophysiol. 2023 12; 34(12):2545-2551. View Abstract

  11. Retroflexed catheter course reduces the risk of right free wall accessory pathway recurrence. J Cardiovasc Electrophysiol. 2023 09; 34(9):1828-1834. View Abstract

  12. Clinical implications of a unique delta wave pattern in patients with left-sided Wolff-Parkinson-White. Europace. 2023 05 19; 25(5). View Abstract

  13. Ablation within the coronary venous system in young patients: A focus on safety. Heart Rhythm. 2023 06; 20(6):900-901. View Abstract

  14. Clinical risk prediction score for postoperative accelerated junctional rhythm and junctional ectopic tachycardia in children with congenital heart disease. Heart Rhythm. 2023 07; 20(7):1011-1017. View Abstract

  15. Ventricular arrhythmias after fibroma resection: Are patients still at risk? Heart Rhythm. 2023 02; 20(2):243-249. View Abstract

  16. Radiofrequency Catheter Ablation for Pediatric Atrioventricular Nodal Reentrant Tachycardia: Impact of Age on Procedural Methods and Durable Success. J Am Heart Assoc. 2022 06 21; 11(12):e022799. View Abstract

  17. Catheter Ablation of Atrioventricular Nodal Reentrant Tachycardia in Patients With Congenital Heart Disease. Circ Arrhythm Electrophysiol. 2022 02; 15(2):e010631. View Abstract

  18. The Evolution of Pediatric and Congenital Electrophysiology as a Subspecialty. Pediatr Cardiol. 2022 Apr; 43(4):776-783. View Abstract

  19. Incessant atrial and ventricular tachycardias associated with an SCN5A mutation. HeartRhythm Case Rep. 2021 Dec; 7(12):806-811. View Abstract

  20. Accessory pathway ablation in Ebstein anomaly: A challenging substrate. Heart Rhythm. 2021 11; 18(11):1844-1851. View Abstract

  21. Conversations With Legends in Cardiac Electrophysiology. JACC Clin Electrophysiol. 2021 05; 7(5):684.e1-684.e8. View Abstract

  22. Lead age as a predictor for failure in pediatrics and congenital heart disease. Pacing Clin Electrophysiol. 2021 04; 44(4):586-594. View Abstract

  23. Risk Factors for Left Ventricular Dysfunction Following Surgical Management of Cardiac Fibroma. Circ Cardiovasc Imaging. 2021 02; 14(2):e011748. View Abstract

  24. Corrigendum to ' Ventricular Arrhythmia and Life-Threatening Events in Patients With Repaired Tetralogy of Fallot' [The American Journal of Cardiology 132 (2020) 126-132]. Am J Cardiol. 2021 Jan 01; 138:133. View Abstract

  25. Difference in the prevalence of intracardiac thrombus on the first presentation of atrial fibrillation versus flutter in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2020 12; 31(12):3243-3250. View Abstract

  26. Risk Factors for Early Recurrence Following Ablation for Accessory Pathways: The Role of Consolidation Lesions. Circ Arrhythm Electrophysiol. 2020 11; 13(11):e008848. View Abstract

  27. Value of provocative electrophysiology testing in the management of pediatric patients after congenital heart surgery. Pacing Clin Electrophysiol. 2020 09; 43(9):901-907. View Abstract

  28. Ventricular Arrhythmia and Life-Threatening Events in Patients With Repaired Tetralogy of Fallot. Am J Cardiol. 2020 10 01; 132:126-132. View Abstract

  29. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population. Heart Rhythm. 2020 06; 17(6):984-990. View Abstract

  30. Examination of pathologic features of the right atrioventricular groove in hearts with Ebstein anomaly and correlation with arrhythmias. Heart Rhythm. 2020 07; 17(7):1092-1098. View Abstract

  31. Outcomes of catheter ablation of anteroseptal and midseptal accessory pathways in pediatric patients. Heart Rhythm. 2020 05; 17(5 Pt A):759-767. View Abstract

  32. Arrhythmia Mechanisms and Outcomes of Ablation in Pediatric Patients With Congenital Heart Disease. Circ Arrhythm Electrophysiol. 2019 11; 12(11):e007663. View Abstract

  33. Long-term results of atrial maze surgery in patients with congenital heart disease. Europace. 2019 Sep 01; 21(9):1345-1352. View Abstract

  34. Interdigitating Myocardial Tongues in Pediatric Cardiac Fibromas: Plausible Substrate for Ventricular Tachycardia and Cardiac Arrest. JACC Clin Electrophysiol. 2019 05; 5(5):563-575. View Abstract

  35. Differentiation of fasciculoventricular fibers from anteroseptal accessory pathways using the surface electrocardiogram. Heart Rhythm. 2019 07; 16(7):1072-1079. View Abstract

  36. Dual-Site Ventricular Pacing in Patients With Fontan Physiology and Heart Block: Does it Mitigate the Detrimental Effects of Single-Site Ventricular Pacing? JACC Clin Electrophysiol. 2018 10; 4(10):1289-1297. View Abstract

  37. Evaluation of left ventricular false tendons in children with idiopathic left ventricular tachycardia. Pacing Clin Electrophysiol. 2018 09; 41(9):1143-1149. View Abstract

  38. Ebstein's Anomaly of the Tricuspid Valve: A Natural Laboratory for Re-Entrant Tachycardias. JACC Clin Electrophysiol. 2018 10; 4(10):1271-1288. View Abstract

  39. Catheter Ablation of Ventricular Arrhythmia for Ebstein's Anomaly in Unoperated and Post-Surgical Patients. JACC Clin Electrophysiol. 2018 10; 4(10):1300-1307. View Abstract

  40. Quality of life and social functioning of former long-stay psychiatric patients transferred into the community: a 10 year follow up study. Soc Psychiatry Psychiatr Epidemiol. 2018 Aug; 53(8):795-801. View Abstract

  41. Utility of incomplete right bundle branch block as an isolated ECG finding in children undergoing initial cardiac evaluation. Congenit Heart Dis. 2018 May; 13(3):419-427. View Abstract

  42. The role of ablation therapy for ventricular tachycardia in patients with tetralogy of Fallot. Heart Rhythm. 2018 05; 15(5):686-687. View Abstract

  43. Cardiac Events During Competitive, Recreational, and Daily Activities in Children and Adolescents With Long QT Syndrome. J Am Heart Assoc. 2017 Sep 21; 6(9). View Abstract

  44. Epicardial ablation of tachyarrhythmia in children: Experience at two academic centers. Pacing Clin Electrophysiol. 2017 Sep; 40(9):1017-1026. View Abstract

  45. The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome. JACC Clin Electrophysiol. 2017 07; 3(7):727-743. View Abstract

  46. Improved understanding of ventricular Tachycardia in patients with tetralogy of Fallot. Eur Heart J. 2017 01 21; 38(4):277-279. View Abstract

  47. Improved understanding of ventricular tachycardia in patients with tetralogy of Fallot. Eur Heart J. 2016 Jun 05. View Abstract

  48. Catheter ablation for atrioventricular nodal reentrant tachycardia in patients with congenital heart disease. Heart Rhythm. 2016 06; 13(6):1228-37. View Abstract

  49. 2015 SPCTPD/ACC/AAP/AHA Training Guidelines for Pediatric Cardiology Fellowship Programs (Revision of the 2005 Training Guidelines for Pediatric Cardiology Fellowship Programs). J Am Coll Cardiol. 2015 Mar 13. View Abstract

  50. Task Force 4: Pediatric Cardiology Fellowship Training in Electrophysiology. J Am Coll Cardiol. 2015 Aug 11; 66(6):706-11. View Abstract

  51. Task Force 4: Pediatric Cardiology Fellowship Training in Electrophysiology. SPCTPD/ACC/AAP/AHA. Circulation. 2015 Aug 11; 132(6):e75-80. View Abstract

  52. Mechanism and ablation of arrhythmia following total cavopulmonary connection. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):318-25. View Abstract

  53. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014 Oct; 30(10):e1-e63. View Abstract

  54. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. Circ Arrhythm Electrophysiol. 2014 Dec; 7(6):1057-63. View Abstract

  55. Sudden death in adult congenital heart disease: risk stratification in 2014. Heart Rhythm. 2014 Oct; 11(10):1735-42. View Abstract

  56. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary: Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e81-e101. View Abstract

  57. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014 Oct; 11(10):e102-65. View Abstract

  58. Psychiatric functioning and quality of life in young patients with cardiac rhythm devices. Pediatrics. 2014 Apr; 133(4):e964-72. View Abstract

  59. Catheter ablation of Wolff-Parkinson-White syndrome in conjoined thoracopagus twins. Heart Rhythm. 2014 Jun; 11(6):1070-2. View Abstract

  60. Utility of preoperative electrophysiologic studies in patients with Ebstein's anomaly undergoing the Cone procedure. Heart Rhythm. 2014 Feb; 11(2):182-6. View Abstract

  61. Incidence of and risk factors for catheterization-induced complete heart block in the pediatric cardiac catheterization laboratory. Circ Arrhythm Electrophysiol. 2014 Feb; 7(1):127-33. View Abstract

  62. Successful surgical management of ventricular fibromas in children. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2602-8. View Abstract

  63. In-hospital arrhythmia development and outcomes in pediatric patients with acute myocarditis. Am J Cardiol. 2014 Feb 01; 113(3):535-40. View Abstract

  64. Update on interventional electrophysiology in congenital heart disease: evolving solutions for complex hearts. Circ Arrhythm Electrophysiol. 2013 Oct; 6(5):1032-40. View Abstract

  65. Hot topics in tetralogy of Fallot. J Am Coll Cardiol. 2013 Dec 10; 62(23):2155-66. View Abstract

  66. Transbaffle mapping and ablation for atrial tachycardias after mustard, senning, or Fontan operations. J Am Heart Assoc. 2013 Sep 19; 2(5):e000325. View Abstract

  67. Research accomplishments in pediatric electrophysiology: a historical review. Congenit Heart Dis. 2013 Sep-Oct; 8(5):362-9. View Abstract

  68. The role of cardiac resynchronization therapy for arterial switch operations complicated by complete heart block. Ann Thorac Surg. 2013 Sep; 96(3):904-9. View Abstract

  69. The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace. 2014 Feb; 16(2):277-83. View Abstract

  70. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation. Int J Cardiol. 2013 Oct 09; 168(4):3940-3. View Abstract

  71. The challenge of atrial tachycardia management in rheumatic heart disease. Pacing Clin Electrophysiol. 2013 Jul; 36(7):791-2. View Abstract

  72. Recommendations for advanced fellowship training in clinical pediatric and congenital electrophysiology: a report from the training and credentialing committee of the pediatric and congenital electrophysiology society. Heart Rhythm. 2013 May; 10(5):775-81. View Abstract

  73. The electrophysiological characteristics of accessory pathways in pediatric patients with intermittent preexcitation. Pacing Clin Electrophysiol. 2013 Sep; 36(9):1117-22. View Abstract

  74. Radiofrequency-assisted transseptal perforation for electrophysiology procedures in children and adults with repaired congenital heart disease. Pacing Clin Electrophysiol. 2013 May; 36(5):607-11. View Abstract

  75. WPW in conjoined thoracopagus twins. Heart Rhythm. 2014 Feb; 11(2):336-7. View Abstract

  76. Multiple accessory pathways in the young: the impact of structural heart disease. Am Heart J. 2013 Jan; 165(1):87-92. View Abstract

  77. Prospective evaluation of defibrillation threshold and postshock rhythm in young ICD recipients. Pacing Clin Electrophysiol. 2012 Dec; 35(12):1487-93. View Abstract

  78. Criminal offending before and after the onset of psychosis: examination of an offender typology. Schizophr Res. 2012 Sep; 140(1-3):198-203. View Abstract

  79. Variable QRS morphologies in Ebstein's anomaly: what is the mechanism? Heart Rhythm. 2013 Jun; 10(6):933-7. View Abstract

  80. Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Circ Heart Fail. 2012 Jul 01; 5(4):462-6. View Abstract

  81. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis. 2012; 7:127-35. View Abstract

  82. Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia. J Am Coll Cardiol. 2011 Oct 25; 58(18):1903-9. View Abstract

  83. Marked QT prolongation and ventricular tachycardia of a transient nature in young children with cardiomyopathy. Pacing Clin Electrophysiol. 2012 Aug; 35(8):e247-50. View Abstract

  84. The electroanatomic mechanisms of atrial tachycardia in patients with tetralogy of Fallot and double outlet right ventricle. J Cardiovasc Electrophysiol. 2011 Sep; 22(9):1013-7. View Abstract

  85. Marketing code of ethics for pediatric cardiology programs. Congenit Heart Dis. 2011 May-Jun; 6(3):209-10. View Abstract

  86. Nonfluoroscopic imaging systems reduce radiation exposure in children undergoing ablation of supraventricular tachycardia. Heart Rhythm. 2011 Apr; 8(4):519-25. View Abstract

  87. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011 Jan 10; 171(1):68-73. View Abstract

  88. Lead extraction in pediatric and congenital heart disease patients. Circ Arrhythm Electrophysiol. 2010 Oct; 3(5):437-44. View Abstract

  89. Epicardial left atrial appendage and biatrial appendage accessory pathways. Heart Rhythm. 2010 Dec; 7(12):1740-5. View Abstract

  90. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A. 2010 May 11; 107(19):8800-5. View Abstract

  91. Atrial remodeling after the Fontan operation. Am J Cardiol. 2009 Dec 15; 104(12):1737-42. View Abstract

  92. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm. 2010; 7(2):193-8. View Abstract

  93. Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol. 2009 Jun; 32(6):779-85. View Abstract

  94. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009 Jan 27; 119(3):445-51. View Abstract

  95. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med. 2008 Dec 08; 168(22):2489-96. View Abstract

  96. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008 Dec 02; 52(23):e143-e263. View Abstract

  97. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008 Dec 02; 118(23):2395-451. View Abstract

  98. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008 Dec 02; 118(23):e714-833. View Abstract

  99. Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann Thorac Surg. 2008 Nov; 86(5):1620-5. View Abstract

  100. Ascending aortic dilation in patients with congenital complete heart block. Heart Rhythm. 2008 Dec; 5(12):1704-8. View Abstract

  101. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009 Jan; 20(1):58-65. View Abstract

  102. Cardiac conduction disturbances and ventricular tachycardia after prolonged propofol infusion in an infant. Pacing Clin Electrophysiol. 2008 Aug; 31(8):1070-3. View Abstract

  103. Ectopic atrial rhythm is a preablation predictor of atrioventricular nodal reentrant tachycardia in children. Pediatr Cardiol. 2008 Nov; 29(6):1066-70. View Abstract

  104. Atrioventricular nodal reentrant tachycardia with 2:1 block in pediatric patients. Heart Rhythm. 2008 Oct; 5(10):1391-5. View Abstract

  105. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008 Apr 29; 51(17):1685-91. View Abstract

  106. Digital music players cause interference with interrogation telemetry for pacemakers and implantable cardioverter-defibrillators without affecting device function. Heart Rhythm. 2008 Apr; 5(4):545-50. View Abstract

  107. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol. 2008 Mar; 31(3):338-43. View Abstract

  108. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease. Pacing Clin Electrophysiol. 2008 Feb; 31 Suppl 1:S38-40. View Abstract

  109. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008 Jan 01; 117(1):85-92. View Abstract

  110. Impact of transvenous ventricular pacing leads on tricuspid regurgitation in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2008 Jan; 21(1):65-8. View Abstract

  111. Interventional electrophysiology in patients with congenital heart disease. Circulation. 2007 Jun 26; 115(25):3224-34. View Abstract

  112. Influenza: evolving strategies in treatment and prevention. Semin Respir Crit Care Med. 2007 Apr; 28(2):144-58. View Abstract

  113. Arrhythmias in adult patients with congenital heart disease. Circulation. 2007 Jan 30; 115(4):534-45. View Abstract

  114. Serosurvey of human metapneumovirus infection in Croatia. Croat Med J. 2006 Dec; 47(6):878-81. View Abstract

  115. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008 Feb; 94(2):211-6. View Abstract

  116. Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study. Psychol Med. 2007 Apr; 37(4):547-57. View Abstract

  117. Cardiac conduction through engineered tissue. Am J Pathol. 2006 Jul; 169(1):72-85. View Abstract

  118. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol. 2006 Jul; 17(7):754-9. View Abstract

  119. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 2006 May 23; 113(20):2391-7. View Abstract

  120. Ablation of nonautomatic focal atrial tachycardia in children and adults with congenital heart disease. J Cardiovasc Electrophysiol. 2006 Apr; 17(4):359-65. View Abstract

  121. Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm. 2006 Mar; 3(3):253-8. View Abstract

  122. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006 Jan; 17(1):41-6. View Abstract

  123. Anesthetic management of the neonate with congenital complete heart block: a 16-year review. Paediatr Anaesth. 2005 Dec; 15(12):1059-66. View Abstract

  124. ACCF/AHA/AAP recommendations for training in pediatric cardiology. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/AHA/AAP Writing Committee to Develop Training Recommendations for Pediatric Cardiology). Circulation. 2005 Oct 18; 112(16):2555-80. View Abstract

  125. ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics. 2005 Dec; 116(6):1574-96. View Abstract

  126. ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 4: recommendations for training guidelines in pediatric cardiac electrophysiology endorsed by the Heart Rhythm Society. J Am Coll Cardiol. 2005 Oct 04; 46(7):1391-5. View Abstract

  127. First appropriate use of automated external defibrillator in an infant. Resuscitation. 2005 Oct; 67(1):135-7. View Abstract

  128. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2005 Oct; 14(1):27-36. View Abstract

  129. Prospective trial of electroanatomically guided, irrigated catheter ablation of atrial tachycardia in patients with congenital heart disease. Heart Rhythm. 2005 Jul; 2(7):700-5. View Abstract

  130. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations. J Cardiovasc Electrophysiol. 2005 Jan; 16(1):69-73. View Abstract

  131. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004 Sep; 1(3):301-8. View Abstract

  132. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):150-9. View Abstract

  133. Outcomes of radiofrequency catheter ablation of atrioventricular reciprocating tachycardia in patients with congenital heart disease. Heart Rhythm. 2004 Jul; 1(2):168-73. View Abstract

  134. Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Am J Cardiol. 2004 Jun 01; 93(11):1449-52, A12. View Abstract

  135. Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation. 2004 Apr 27; 109(16):1994-2000. View Abstract

  136. Recent advances in pacemaker and implantable defibrillator therapy for young patients. Curr Opin Cardiol. 2004 Mar; 19(2):91-6. View Abstract

  137. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol. 2004 Mar 01; 93(5):582-7. View Abstract

  138. Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg. 2004 Mar; 127(3):721-9. View Abstract

  139. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol. 2004 Jan; 15(1):72-6. View Abstract

  140. Radiofrequency catheter ablation of septal accessory pathways in the pediatric age group. Am J Cardiol. 2003 Oct 15; 92(8):947-50. View Abstract

  141. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol. 2003 Oct 01; 92(7):871-6. View Abstract

  142. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol. 2003 Apr; 14(4):344-9. View Abstract

  143. Pericaval and periannular intra-atrial reentrant tachycardias in patients with congenital heart disease. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):119-25. View Abstract

  144. Arrhythmias in patients with congenital heart disease. Card Electrophysiol Rev. 2002 Dec; 6(4):422-30. View Abstract

  145. Circadian and seasonal variation of malignant arrhythmias in a pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2002 Oct; 13(10):1009-14. View Abstract

  146. Anticipatory use of venoarterial extracorporeal membrane oxygenation for a high-risk interventional cardiac procedure. Respir Care. 2002 Sep; 47(9):1002-6. View Abstract

  147. Prevalence of and risk factors for atrial fibrillation and intra-atrial reentrant tachycardia among patients with congenital heart disease. Am J Cardiol. 2002 Aug 01; 90(3):338-40. View Abstract

  148. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial re-entrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 2002 Jun 05; 39(11):1827-35. View Abstract

  149. NASPE Expert Consensus Conference: Radiofrequency catheter ablation in children with and without congenital heart disease. Report of the writing committee. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol. 2002 Jun; 25(6):1000-17. View Abstract

  150. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol. 2001 Dec; 24(12):1789-94. View Abstract

  151. Spontaneously terminating apparent ventricular fibrillation during transesophageal electrophysiological testing in infants with Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 2001 Dec; 24(12):1816-8. View Abstract

  152. Postoperative ectopic atrial tachycardia in children with congenital heart disease. Am J Cardiol. 2001 Nov 15; 88(10):1169-72. View Abstract

  153. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2001 Oct; 12(10):1097-101. View Abstract

  154. Atrioventricular reciprocating tachycardia involving twin atrioventricular nodes in patients with complex congenital heart disease. J Cardiovasc Electrophysiol. 2001 Jun; 12(6):671-9. View Abstract

  155. Paucity of sinus node dysfunction following repair of sinus venosus defects in children. Am J Cardiol. 2001 May 15; 87(10):1223-6; A8. View Abstract

  156. Multi atrial maco-re-entry circuits in adults with repaired congenital heart disease: entrainment mapping combined with three-dimensional electroanatomic mapping. J Am Coll Cardiol. 2001 May; 37(6):1665-76. View Abstract

  157. Electroanatomic mapping of entrained and exit zones in patients with repaired congenital heart disease and intra-atrial reentrant tachycardia. Circulation. 2001 Apr 24; 103(16):2060-5. View Abstract

  158. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001 Jan; 121(1):28-41. View Abstract

  159. Electroanatomic characterization of conduction barriers in sinus/atrially paced rhythm and association with intra-atrial reentrant tachycardia circuits following congenital heart disease surgery. J Cardiovasc Electrophysiol. 2001 Jan; 12(1):17-25. View Abstract

  160. Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope. J Virol. 2000 Nov; 74(21):10165-75. View Abstract

  161. Location of acutely successful radiofrequency catheter ablation of intraatrial reentrant tachycardia in patients with congenital heart disease. Am J Cardiol. 2000 Nov 01; 86(9):969-74. View Abstract

  162. Estimation of atrial response to entrainment pacing using electrograms recorded from remote sites. J Cardiovasc Electrophysiol. 2000 Nov; 11(11):1215-22. View Abstract

  163. Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome. J Pediatr. 2000 Apr; 136(4):481-9. View Abstract

  164. Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent protein. J Gen Virol. 2000 Mar; 81(Pt 3):709-18. View Abstract

  165. Psychological functioning in children and adolescents undergoing radiofrequency catheter ablation. Psychosomatics. 2000 Mar-Apr; 41(2):134-9. View Abstract

  166. Value of programmed ventricular stimulation in patients with congenital heart disease. J Cardiovasc Electrophysiol. 1999 Aug; 10(8):1033-44. View Abstract

  167. Characteristics, management, and midterm outcome in infants with atrioventricular nodal reentry tachycardia. Am J Cardiol. 1998 Oct 15; 82(8):956-60. View Abstract

  168. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol. 1998 Aug 15; 82(4):525-7. View Abstract

  169. Long-term performance of bipolar epicardial atrial pacing using an active fixation bipolar endocardial lead. Pacing Clin Electrophysiol. 1998 May; 21(5):1098-104. View Abstract

  170. Five-year experience with radiofrequency catheter ablation: implications for management of arrhythmias in pediatric and young adult patients. J Pediatr. 1997 Dec; 131(6):878-87. View Abstract

  171. Left ventricular mechanics and geometry in patients with congenital complete atrioventricular block. Circulation. 1997 Nov 18; 96(10):3430-5. View Abstract

  172. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997 Oct; 30(4):1032-8. View Abstract

  173. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. J Cardiovasc Electrophysiol. 1997 Jul; 8(7):812-7. View Abstract

  174. Spontaneous accelerated junctional rhythm: an unusual but useful observation prior to radiofrequency catheter ablation for atrioventricular node reentrant tachycardia in young patients. Pacing Clin Electrophysiol. 1997 Jun; 20(6):1654-61. View Abstract

  175. Syncope in the pediatric patient. Cardiol Clin. 1997 May; 15(2):277-94. View Abstract

  176. Predictors of permanence of successful radiofrequency lesions created with controlled catheter tip temperature. Pacing Clin Electrophysiol. 1997 May; 20(5 Pt 1):1283-91. View Abstract

  177. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol. 1997 Apr; 29(5):1046-53. View Abstract

  178. Intra-atrial reentrant tachycardia after palliation of congenital heart disease: characterization of multiple macroreentrant circuits using fluoroscopically based three-dimensional endocardial mapping. J Cardiovasc Electrophysiol. 1997 Mar; 8(3):259-70. View Abstract

  179. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg. 1997 Jan; 113(1):80-6. View Abstract

  180. Multipolar endocardial mapping of the right heart using a basket catheter: acute and chronic animal studies. Pacing Clin Electrophysiol. 1997 Jan; 20(1 Pt 1):51-9. View Abstract

  181. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am J Med Genet. 1996 Oct 02; 65(1):27-35. View Abstract

  182. Low-temperature mapping predicts site of successful ablation while minimizing myocardial damage. Circulation. 1996 Aug 01; 94(3):253-7. View Abstract

  183. Conversion of modified Fontan procedure to lateral atrial tunnel cavopulmonary anastomosis. J Thorac Cardiovasc Surg. 1996 Jun; 111(6):1169-76. View Abstract

  184. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation. 1996 May 15; 93(10):1791-5. View Abstract

  185. Long-term outcome in patients with pacemakers following the Fontan operation. Am J Cardiol. 1996 Apr 15; 77(10):887-9. View Abstract

  186. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg. 1996 Apr; 111(4):833-9; discussion 839-40. View Abstract

  187. Embolic complications associated with radiofrequency catheter ablation. Atakr Investigator Group. Am J Cardiol. 1996 Mar 15; 77(8):655-8. View Abstract

  188. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J. 1996 Jan; 131(1):66-72. View Abstract

  189. Myocardial mechanics before and after ablation of chronic tachycardia. Pacing Clin Electrophysiol. 1996 Jan; 19(1):42-9. View Abstract

  190. High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings. J Electrocardiol. 1996; 29 Suppl:234-40. View Abstract

  191. Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol. 1995 Dec; 6(12):1129-48. View Abstract

  192. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Am Heart J. 1995 Oct; 130(4):791-7. View Abstract

  193. Conversion of atrial flutter in pediatric patients by transesophageal atrial pacing: a safe, effective, minimally invasive procedure. Am Heart J. 1995 Aug; 130(2):323-7. View Abstract

  194. Use of adenosine-sensitive nondecremental accessory pathways in assessing the results of radiofrequency catheter ablation. Am J Cardiol. 1995 Jun 15; 75(17):1278-81. View Abstract

  195. Factors influencing impedance during radiofrequency ablation in humans. Chin Med J (Engl). 1995 Jun; 108(6):450-5. View Abstract

  196. Benefits and potential risks of atrial antitachycardia pacing after repair of congenital heart disease. Pacing Clin Electrophysiol. 1995 May; 18(5 Pt 1):1005-16. View Abstract

  197. Effects of propofol or isoflurane anesthesia on cardiac conduction in children undergoing radiofrequency catheter ablation for tachydysrhythmias. Anesthesiology. 1995 Apr; 82(4):884-7. View Abstract

  198. Radiofrequency ablation of intra-atrial reentrant tachycardia after surgical palliation of congenital heart disease. Circulation. 1995 Feb 01; 91(3):707-14. View Abstract

  199. Arrhythmias and intracardiac conduction after the arterial switch operation. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):303-10. View Abstract

  200. Arrhythmias in children prenatally exposed to cocaine. Arch Pediatr Adolesc Med. 1994 Nov; 148(11):1163-9. View Abstract

  201. Efficacy and safety of radiofrequency ablation in infants and young children < 18 months of age. Am J Cardiol. 1994 Nov 01; 74(9):944-7. View Abstract

  202. Programmed atrial stimulation via the esophagus for management of supraventricular arrhythmias in infants and children. Am J Cardiol. 1994 Aug 15; 74(4):353-6. View Abstract

  203. Staged pacing therapy for congenital complete heart block in premature infants. Am J Cardiol. 1994 Aug 15; 74(4):412-3. View Abstract

  204. Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children. Circulation. 1994 Jul; 90(1):492-9. View Abstract

  205. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med. 1994 May 26; 330(21):1481-7. View Abstract

  206. Multipolar endocardial mapping of the right atrium during cardiac catheterization: description of a new technique. J Am Coll Cardiol. 1993 Oct; 22(4):1105-10. View Abstract

  207. Radiofrequency ablation of accessory pathways associated with congenital heart disease including heterotaxy syndrome. Am J Cardiol. 1993 Sep 15; 72(9):689-93. View Abstract

  208. Catheter ablation of accessory atrioventricular pathways in young patients: use of long vascular sheaths, the transseptal approach and a retrograde left posterior parallel approach. J Am Coll Cardiol. 1993 Mar 01; 21(3):571-83. View Abstract

  209. Variable location of accessory pathways associated with the permanent form of junctional reciprocating tachycardia and confirmation with radiofrequency ablation. Am J Cardiol. 1992 Dec 15; 70(20):1559-64. View Abstract

  210. Transcatheter ablation of ectopic atrial tachycardia in young patients using radiofrequency current. Circulation. 1992 Oct; 86(4):1138-46. View Abstract

  211. Transcatheter ablation for pediatric tachyarrhythmias using radiofrequency electrical energy. Pediatr Ann. 1991 Jul; 20(7):386, 388-92. View Abstract

  212. Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J. 1989 Dec; 118(6):1193-8. View Abstract

  213. Results of the arterial switch operation for transposition of the great arteries with ventricular septal defect. Surgical considerations and midterm follow-up data. Circulation. 1989 Dec; 80(6):1689-705. View Abstract

  214. Midterm results after the arterial switch operation for transposition of the great arteries with intact ventricular septum: clinical, hemodynamic, echocardiographic, and electrophysiologic data. Circulation. 1988 Jun; 77(6):1333-44. View Abstract

  215. Late results in patients with tetralogy of Fallot repaired during infancy. Circulation. 1988 May; 77(5):1062-7. View Abstract

  216. Cerebral embolism resulting from an intracardiac tumor in tuberous sclerosis. Pediatr Neurol. 1986 Mar-Apr; 2(2):108-10. View Abstract

  217. Electrocardiogram of the premature infant at 1 year of age. Pediatrics. 1986 Mar; 77(3):353-6. View Abstract

I’ve been privileged to work at this hospital for more than 30 years, which has given me the opportunity to follow some patients from infancy into adulthood. I believe continuity is a vital part of caring for complex cardiac patients, and is especially important in treatment of heart rhythm disorders, which is my area of specialization. Not only does continuity improve care for the patient, but it’s also the best way for clinicians to learn about the long-term effectiveness of our various therapies, leading to better strategies for treating the most difficult heart conditions.

BESbswy